• Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join A Project
    • All Projects
    • Chemical Safety Library
    • DataFAIRy Bioassay Annotation Project
    • Diversity & Inclusion in STEM Leadership Program
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Informed Consent Blockchain Project
    • Microbiome Project
    • Semantic Enrichment of ELN Data
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Controlled Substance Compliance
    • Lab of the Future
    • Quantum Computing
    • User Experience for Life Sciences
  • Submit an Idea
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
    • Global Knowledge-Sharing Events
    • Past Webinars
  • News

  • Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join A Project
    • All Projects
    • Chemical Safety Library
    • DataFAIRy Bioassay Annotation Project
    • Diversity & Inclusion in STEM Leadership Program
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Informed Consent Blockchain Project
    • Microbiome Project
    • Semantic Enrichment of ELN Data
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Controlled Substance Compliance
    • Lab of the Future
    • Quantum Computing
    • User Experience for Life Sciences
  • Submit an Idea
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
    • Global Knowledge-Sharing Events
    • Past Webinars
  • News
Become a Member
Search

Search...

  • Menu

Driving Toward Adoption of Microphysiological Systems in Drug R&D

Webinar Summary

 

Innovation applications of microphysiological systems (MPS) have been growing over the past decade, especially with respect to the use of complex human tissues for assessing safety of drug candidates – but broad industry adoption of MPS methods has not yet become a reality.

 

This webinar will address some recent advances in microphysiological systems development and begin to explore the barriers to increased incorporation of MPS to improve drug safety assessment and to provide safer, more effective drugs into the clinical pipeline.

 

Panel Moderator:

  • Mary Ellen Cosenza, NDA Partners

 

Panelists:

  • Rhiannon David, MPS Lead, AstraZeneca
  • Reyk Horland, VP Business Development, TissUse
  • David Jacobson-Kram, Consultant, toxrox (fmr Associate Director, CDER, FDA)

Access the Recording

We will email you the recording.

Posted on May 1, 2020 by Yasheaka Oakley
Categories: Pistoia Webinars

Tags: drug delivery, research, webinar


Events

07 Jul 2022

Pistoia Alliance Global Knowledge-Sharing: Emerging Science & Technology in Japan Life Sciences

Book this event >
19 Jul 2022

Get to Know the Pistoia Alliance: New Member Orientation

Book this event >
28 Jul 2022

Webinar: Ontologies in Action, Role in Data-Centric Biomedical Projects

Book this event >
03 Aug 2022

AI/ML Webinar: Trustworthy AI

Book this event >
Follow Us
Active Projects
IDMP Ontology Project
Diversity & Inclusion in STEM Leadership Program
Unified Integrated Knowledge Base
Microbiome Project
Data Visualization Project
Methods Hub Project
Informed Consent Blockchain Project
Quality Generation and Ethical Use of Digital Health Data in Clinical Studies
Semantic Enrichment of ELN Data Project (SEED)
FAIR Implementation Project
Sign up for Pistoia Alliance Communications

© Copyright Pistoia Alliance, Inc., 2020 | Contact us at info@pistoiaalliance.org | Terms of use | Privacy Statement

By clicking "Agree" you are agreeing to the following terms and conditions for the use of the UDM XML Schema definition.

This website intends to use cookies to improve the site and provide you with a better browsing experience. If you select "Continue" or continue to browse the site without customizing your choices, you agree to our use of cookies. Find out more in our Online Privacy Statement.

Continue More Info